Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Equity Average (2023 - 2026)

Cannabis Bioscience International Holdings filings provide 4 years of Equity Average readings, the most recent being -$1.4 million for Q1 2026.

  • On a quarterly basis, Equity Average fell 19.91% to -$1.4 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$1.4 million, a 19.91% decrease, with the full-year FY2025 number at -$1.1 million, down 34.23% from a year prior.
  • Equity Average reached -$1.4 million in Q1 2026 per CBIH's latest filing, down from -$1.3 million in the prior quarter.
  • The five-year high for Equity Average was -$443479.5 in Q1 2023, with the low at -$1.4 million in Q1 2026.
  • A 4-year average of -$985595.0 and a median of -$1.1 million in 2024 define the central range for Equity Average.
  • Year-over-year, Equity Average tumbled 104.97% in 2024 and then dropped 12.91% in 2025.
  • Year by year, Equity Average stood at -$779673.0 in 2023, then plummeted by 40.45% to -$1.1 million in 2024, then dropped by 19.14% to -$1.3 million in 2025, then decreased by 8.47% to -$1.4 million in 2026.
  • Per Business Quant, the three most recent readings for CBIH's Equity Average are -$1.4 million (Q1 2026), -$1.3 million (Q4 2025), and -$1.2 million (Q3 2025).